Skip to main content

Table 1 Mice used in ex vivo studies

From: Glial reactivity in a mouse model of beta-amyloid deposition assessed by PET imaging of P2X7 receptor and TSPO using [11C]SMW139 and [18F]F-DPA

 

Age (mo)

Genotype

NGENDER

NTOTAL

F

M

Ex vivo brain autoradiography

5

TG

3

1

4

 

WT

2

2

4

8–10

TG

3

2

5

 

WT

2

5

7

12

TG

–

2

2

 

WT

–

1

1

14

TG

1

1

2

 

WT

3

2

5

P2X7 immunohistochemical staining

5

TG

1

–

1

 

WT

–

1

1

8–10

TG

1

1

2

 

WT

–

2

2

12

TG

–

2

2

 

WT

–

2

2

14

TG

1

–

1

 

WT

1

–

1

15

TG

1

–

1

 

WT

–

–

–

TSPO & P2Y12 immunohistochemical staining

5

TG

2

1

3

 

WT

1

2

3

8–10

TG

2

1

3

 

WT

1

2

3

12

TG

–

3

3

 

WT

–

2

2

14

TG

2

1

3

 

WT

4

–

4

15

TG

1

2

3

 

WT

–

–

–

 

Δt (min)

Genotype

NGENDER

N TOTAL

F

M

Plasma radiometabolites analysis

10

TG

4

9

13

 

WT

8

8

16

30

TG

3

–

3

 

WT

5

8

13

45

TG

3

–

3

 

WT

9

2

11

Brain radiometabolites analysis

10

TG

4

2

6

 

WT

7

3

10

30

TG

3

–

3

 

WT

5

9

14

45

TG

3

–

3

 

WT

9

1

10

  1. mo month, min minutes, F female, M male, TG transgenic, WT wild type